Cancer Family
Carcinoma
CI-CAN-00000114Explore in graph →
7,369 active trials118 approved drugs1,149 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000114Explore in graph →
Clinical trials
25,729 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (3,405)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00942058 | Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell Cancer(CA9CRM) | terminated | — | 16 | Centre Hospitalier Universitaire de Saint EtienneOTHER | 1 | Jan 29, 2014 | clinicaltrials |
| NCT00989092 | Darbepoetin Alfa and Anemia of Cancer | terminated | Phase 2 | 287 | AmgenINDUSTRY | 0 | Jan 29, 2014 | clinicaltrials |
| NCT01677390 | A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma | terminated | Phase 1 | 4 | Seagen Inc.INDUSTRY | 1 | Jan 28, 2014 | clinicaltrials |
| NCT01356368 | Customizing First Line Chemotherapy in Advanced Non-Small Cell Lung Cancer(Customizing) | terminated | Phase 2 | 3 | National Guard Health AffairsOTHER_GOV | 1 | Jan 22, 2014 | clinicaltrials |
| NCT01063478 | Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC(RAD001) | terminated | Phase 1 | 3 | University of ChicagoOTHER | 1 | Jan 17, 2014 | clinicaltrials |
| NCT00095693 | Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer | terminated | Phase 2 | 25 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2014 | clinicaltrials |
| NCT00265603 | Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer | terminated | Phase 1 | 16 | Atlantic Health SystemOTHER | 1 | Jan 16, 2014 | clinicaltrials |
| NCT01473693 | Changes in Brain Structure Related to Systemic Chemotherapy Treatment: A Prospective Study in Individuals Diagnosed With Non-small Cell Lung Cancer Utilizing High-resolution Structural Magnetic Resonance Imaging | terminated | — | 1 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 16, 2014 | clinicaltrials |
| NCT01640730 | Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer | terminated | Phase 2 | 1 | KangLaiTe USAINDUSTRY | 1 | Jan 16, 2014 | clinicaltrials |
| NCT01097083 | Coriolus Versicolor as Palliative Therapy Compared to Placebo in Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma | terminated | Phase 2 | 20 | National University Hospital, SingaporeOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00596830 | Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology | terminated | Phase 3 | 681 | PfizerINDUSTRY | 26 | Jan 13, 2014 | clinicaltrials |
| NCT01096732 | Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS)(HIPPoS) | terminated | Phase 2 | 3 | Lisa BaxOTHER | 1 | Jan 8, 2014 | clinicaltrials |
| NCT01202890 | Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer | terminated | Phase 1 | 1 | New Mexico Cancer Research AllianceOTHER | 1 | Jan 8, 2014 | clinicaltrials |
| NCT00613730 | Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint(APPRISE 1) | terminated | Phase 2 | 3 | AmgenINDUSTRY | 0 | Jan 6, 2014 | clinicaltrials |
| NCT01871480 | CIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung Cancer | terminated | Phase 2 | 50 | Kunming Medical UniversityOTHER | 1 | Dec 30, 2013 | clinicaltrials |
| NCT01479023 | Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors | terminated | Phase 1 | 12 | Washington University School of MedicineOTHER | 1 | Dec 20, 2013 | clinicaltrials |
| NCT00071942 | Vaccine Therapy in Treating Patients With Metastatic Breast Cancer | terminated | Phase 1 | 22 | National Cancer Institute (NCI)NIH | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00887315 | The Synergistic Metastases Annihilation With Radiotherapy and Docetaxel (Taxotere) [SMART] Trial for Non-Small Cell Lung Cancer (NSCLC)(SMART) | terminated | Phase 2 | 11 | University of ChicagoOTHER | 1 | Dec 6, 2013 | clinicaltrials |
| NCT00701870 | Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer | terminated | Phase 2 | 1 | TelikINDUSTRY | 1 | Nov 27, 2013 | clinicaltrials |
| NCT01063998 | A Urinary Tumor Marker (Kidney Injury Molecule-1) for the Detection of Renal Cell Carcinoma | terminated | — | 23 | Jason HafronOTHER | 1 | Nov 8, 2013 | clinicaltrials |
| NCT01128803 | Immunotherapy of Hepatocellular Carcinoma by Induction of Anti-alpha Fetoprotein Response | terminated | Phase 1 / Phase 2 | 1 | Nantes University HospitalOTHER | 1 | Nov 7, 2013 | clinicaltrials |
| NCT00365183 | Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer | terminated | Phase 2 | 74 | Pharmacyclics LLC.INDUSTRY | 1 | Oct 31, 2013 | clinicaltrials |
| NCT01060514 | Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer | terminated | Phase 1 | 8 | Northwestern UniversityOTHER | 1 | Oct 30, 2013 | clinicaltrials |
| NCT01215838 | MRI of the Liver With Eovist | terminated | — | 4 | University of WashingtonOTHER | 0 | Oct 14, 2013 | clinicaltrials |
| NCT00110344 | Research Study for Patients With Metastatic Renal Cell Carcinoma | terminated | Phase 2 | 1 | BayerINDUSTRY | 1 | Oct 11, 2013 | clinicaltrials |
| NCT00536107 | Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | terminated | Phase 4 | 14 | AstraZenecaINDUSTRY | 1 | Oct 1, 2013 | clinicaltrials |
| NCT01192763 | RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer | terminated | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT01705340 | Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery | terminated | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00203866 | Trial of G250 Peptide and IL-2 Following Surgical Resection of Locally Advanced/Metastatic Renal Cell Carcinoma | terminated | Phase 2 | 40 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00862082 | Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) | terminated | Phase 1 / Phase 2 | 14 | Proacta, IncorporatedINDUSTRY | 4 | Aug 23, 2013 | clinicaltrials |
| NCT00708877 | Liver Transplantation for Cholangiocarcinoma | terminated | N/A | 5 | University of UtahOTHER | 1 | Jul 30, 2013 | clinicaltrials |
| NCT00673049 | Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer(NSCLC) | terminated | Phase 3 | 583 | PfizerINDUSTRY | 27 | Jul 24, 2013 | clinicaltrials |
| NCT00557830 | Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma | terminated | Phase 2 | 12 | Accelerated Community Oncology Research NetworkOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00896467 | Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy | terminated | — | 200 | Centre Oscar LambretOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT01073644 | Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients | terminated | — | 3 | PfizerINDUSTRY | 1 | Jul 4, 2013 | clinicaltrials |
| NCT00098527 | FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer | terminated | Phase 2 | 20 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00098618 | Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer | terminated | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00906360 | Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck | terminated | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT01282333 | Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer | terminated | Phase 1 | 44 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT01337154 | First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer | terminated | Phase 2 | 140 | CytRxINDUSTRY | 6 | Jun 28, 2013 | clinicaltrials |
| NCT00773383 | A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Having Received Tarceva Monotherapy. | terminated | Phase 2 | 35 | Hoffmann-La RocheINDUSTRY | 4 | Jun 24, 2013 | clinicaltrials |
| NCT01257035 | Predictive Value of 18F-FAZA in Rectum Cancer(FAZA) | terminated | — | 21 | Vejle HospitalOTHER | 1 | Jun 17, 2013 | clinicaltrials |
| NCT00087269 | Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical Resection | terminated | Phase 2 | 110 | National Cancer Institute (NCI)NIH | 1 | Jun 6, 2013 | clinicaltrials |
| NCT00084461 | Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors | terminated | Phase 2 | 25 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00615628 | Inheritance of Osteosarcoma & Paget's Disease Through Chromosome 18: | terminated | — | 8 | State University of New York - Upstate Medical UniversityOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00697476 | Study of Oral Vorinostat in Combination With Topotecan in Patients With Chemosensitive Recurrent SCLC | terminated | Phase 1 / Phase 2 | 2 | Armando Santoro, MDOTHER | 1 | May 29, 2013 | clinicaltrials |
| NCT00758134 | Trastuzumab Therapy in Non-Small Cell Lung Cancer Patients | terminated | Phase 2 | 9 | Armando Santoro, MDOTHER | 1 | May 29, 2013 | clinicaltrials |
| NCT01194427 | A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer | terminated | Phase 2 | 2 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | May 17, 2013 | clinicaltrials |
| NCT00012246 | Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | terminated | Phase 2 | 7 | The University of Texas Medical Branch, GalvestonOTHER | 1 | May 16, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jan 29, 2014source: clinicaltrials